Clinical journal of oncology nursing最新文献

Background: A hospital-community-family network for peripherally inserted central catheter (PICC) management allows the families of children with pediatric cancer to select a PICC nursing institution based on their place of residence and healthcare coverage. PICC family caregiving support across a chemotherapy regimen helps to mitigate discomfort.

Objectives: The purpose of this study was to implement a medical alliance consortium (MAC) model PICC care network and to evaluate its effectiveness in outpatients with pediatric cancer in China.

Methods: A MAC network was established among medical staff from a tertiary hospital and 26 regional community hospitals. In total, 180 children with leukemia undergoing PICC placement were randomized to groups receiving routine continous care or care through the network. Nurse satisfaction, patient satisfaction, and patient outcomes were evaluated.

Findings: The MAC group showed fewer complications than the control group (p < 0.05). Children in the MAC group showed superior self-management capabilities. Patients' families and nurses reported higher satisfaction with the MAC model.

Background: Gestational trophoblastic (GT) disease is a continuum of gynecologic disorders that begins with a hydatidiform mole and may progress to GT neoplasia.

Objectives: The purpose of this article is to review the pathophysiology and clinical manifestations associated with GT disease and provide the advanced practice RN with evidence-based management strategies to use when caring for patients.

Methods: A case study details a woman aged 42 years with a hydatidiform mole who underwent multiple uterine curettage procedures. The disease progressed to GT neoplasia, characterized by elevated human chorionic gonadotropin (hCG) levels. The patient completed a 10-week course of IV methotrexate, and hCG levels returned to normal range.

Findings: Serial monitoring of hCG levels is paramount when caring for a patient with GT disease. The advanced practice RN should recognize the pathologic significance of rising hCG levels, report these trends to the treating physician, and aim to improve health outcomes.

Background: The ipsilateral arm is not used for blood pressure, phlebotomy, or IV access postmastectomy or post-lymph node removal or biopsy. The non-evidence-based practice of blanket forbidding of ipsilateral arm use can result in inaccurate calf blood pressure measurements, foot stick blood draw orders, and an increased need for tunneled central venous catheters.

Objectives: This project piloted a practice change and allowed for the use of the ipsilateral arm in patients with breast cancer.

Methods: The team used the Johns Hopkins Evidence-Based Practice Model to implement a practice change for hematology-oncology inpatients with breast cancer and lymph node involvement, removal, or biopsy, or mastectomy history.

Findings: Twelve months after implementation, more than 100 patients with breast cancer participated with zero incidences of resulting lymphedema. There were no foot stick orders or calf blood pressures in patients when the ipsilateral arm was used. After 16 months, the practice change became a systemwide policy.

Background: This review describes the current state of noninvasive continuous temperature monitoring (CTM) in oncology and future directions for CTM.

Objectives: MEDLINE®, Google Scholar™, and ClinicalTrials.gov databases were searched for articles published from April 1, 2019, to April 30, 2024, to evaluate the use of wearable CTM devices. The validity of the evidence and the regulatory status of U.S. Food and Drug Administration 510(k)-cleared devices were assessed to determine the benefits and limitations of using CTM for detecting febrile neutropenia.

Methods: In total, 178 unique studies were screened, 64 were selected for additional review, and 15 met inclusion criteria and used one of four brands of 510(k)-cleared medical-grade devices.

Findings: The benefits of CTM identified in this review include improved patient outcomes, increased cost savings, ease and reliability of use, increased patient mobility, and the ability to wirelessly and remotely monitor patients. The feasibility, usability, and satisfaction in patients and caretakers were established.

Clinicians have practiced precision oncology in breast cancer care for decades. Genetic and genomic testing technology has allowed for personalized cancer risk assessment, prognosis determination, and treatment of the disease.

Virtual reality (VR) technology has been studied in oncology nursing with favorable results. A comprehensive cancer center provided a Take-a-Break VR program. Participants reported that they would repeat this VR program as a.

Curiosity requires attentiveness, inquisitiveness, critical thinking, mindfulness, and reflection; it is closely connected to wonder and awe. It has empirical links to happiness, mattering, positive social relationships, enha.

Background: Nutrition is an essential part of care for patients with cancer, but healthcare providers lack confidence in discussing nutrition-related topics with their patients. Nurses provided with education can increase their confidence in teaching patients about nutrition; however, data are limited on the effects of this education on patient care.

Objectives: The purpose of this project was to provide education for outpatient oncology nurses about nutrition and assess its impact on nurses' confidence, use of nutrition resources, and patient care.

Methods: This quality improvement project used a pre- and postsurvey to evaluate the implementation of evidence-based, nutrition-focused nurse education. Data were collected on nurse confidence, patient nutrition needs, patient experiences with nutrition education, and use of nutrition resources.

Findings: The education was completed by 16 infusion nurses. Implementation of nutrition-focused education for outpatient oncology nurses increased nurse confidence and the use of nutrition resources. The most frequent nutrition complaint among patients was related to weight loss, with nearly half of nutrition consultations placed for that reason.

People with cancer can present with coexisting physical disabilities that may not be a result of their malignancy or treatment-related complications. Healthcare providers can recognize the unique needs of patients with physic.

Background: Vascular endothelial growth factor receptor-tyrosine kinase inhibitors (VEGFR-TKIs), alone or in combination with immune checkpoint inhibitors, are part of the standard of care in treating metastatic renal cell carcinoma (mRCC). VEGFR-TKIs are associated with acute, chronic, and potentially dose-limiting toxicities requiring treatment modifications and discontinuations.

Objectives: This article summarizes evidence-based practices that oncology nurses may use to manage VEGFR-TKI adverse events and improve quality of life in patients with mRCC.

Methods: Pivotal clinical trial publications of VEGFR-TKIs in mRCC were reviewed to evaluate the adverse event profile of each drug and effective management strategies.

Findings: Patients with mRCC treated with VEGFR-TKIs can benefit from education about potential side effects, consistent monitoring, and early detection of adverse events, as well as appropriate interventions to improve treatment tolerability, adherence, outcomes, and quality of life.